 |
Archives
2008-May-30: New Analysis Shows Patients Who Treat Their Migraine Pain Early With Trexima(TM) Have Higher Sustained Pain-Free Rates
2008-May-30: TorreyPines Therapeutics Initiates Phase IIb Clinical Trial In Acute Migraine For Lead Compound Tezampanel Part 2
2008-May-30: TorreyPines Therapeutics Initiates Phase IIb Clinical Trial In Acute Migraine For Lead Compound Tezampanel Part 2
2008-May-30: Device Chills Out Migraines Without Medication Gets FDA Clearance Part 2
2008-May-30: Overuse Of Codeine, Oxycodone And Barbiturates Increases Risk Of Chronic Migraine
2008-May-30: Chiropractic and Headache
2008-May-30: Combination Treatment For Migraine More Effective Than Single Medications
2008-May-30: Headaches And Abdominal Pain Cluster In Families
2008-May-30: Acupuncture cuts tension headache rates by almost half
2008-May-30: Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
2008-May-30: Migraine Treatment Also Appears Effective For Cluster Headaches
2008-May-30: Drug Delivery Technology Influence On Pharmaceutical Strategies Increasing - Greystone Associates Finds Recent Deals Reflecting A New Business Reality
2008-May-29: Tezampanel Meets Primary Endpoint In Phase IIb Clinical Trial In Acute Migraine Headache Part 5
2008-May-29: European survey underscores migraine burden Part 2
2008-May-29: Caretek Medical Announces Lead Drug Candidate For ImplaJect(R) Development, Sumatriptan Succinate Part 2
2008-May-29: Device Chills Out Migraines Without Medication Gets FDA Clearance Part 2
2008-May-27: Caretek Medical Announces Lead Drug Candidate For ImplaJect(R) Development
2008-May-25: Drug Delivery Technology Influence On Pharmaceutical Strategies Increasing - Greystone Associates Finds Recent Deals Reflecting A New Business Reality
2008-May-23: European survey underscores migraine burden Part 4
2008-May-21: New Data Show Consistent Efficacy And Tolerability Of Trexima(R) (sumatriptan Succinate/naproxen Sodium) Across Multiple Migraine Attacks
2008-May-19: New Data Demonstrate Sustained Efficacy Of Single Tablet Combination Migraine Therapy Compared To Monotherapy
2008-May-17: NMT Medical Receives FDA Approval To Modify MIST II PFO Migraine Study In The United States Part 3
2008-May-15: Off-label use of migraine drug gives children relief Part 2
2008-May-13: Treximaà (sumatriptan/naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks Part 2
2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
|
|